Xia 3
Payments companies reported to CMS as associated with Xia 3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xia 3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xia 3
These are the largest totals companies reported as associated with Xia 3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Rhee | Atlanta, GA | Orthopaedic Surgery of The Spine | $79,246.76 |
| Daniel Refai | Atlanta, GA | Neurological Surgery | $43,842.70 |
| Hansen Yuan | Syracuse, NY | Orthopaedic Surgery of The Spine | $41,961.28 |
| Jeffrey Fischgrund | Southfield, MI | Orthopaedic Surgery | $41,625.00 |
| Joseph Errico | Temecula, CA | Psychiatry | $40,110.50 |
| Michael Schmitz | Atlanta, GA | Orthopaedic Surgery | $27,422.84 |
| Jose Valerio | South Miami, FL | Neurological Surgery | $19,038.68 |
| Matthew Mcgirt | Charlotte, NC | Neurological Surgery | $13,500.00 |
| William Spiker | Salt Lake City, UT | Orthopaedic Surgery of The Spine | $10,910.32 |
| Stephen George | Miami, FL | Orthopaedic Surgery of The Spine | $10,563.00 |
Prescribed Xia 3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.